✦ LIBER ✦

PCN15 COST-EFFECTIVENESS OF NEW TARGETED THERAPY SUNITINIB MALATE AS SECOND LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA IN ARGENTINA

✍ Scribed by EC Aiello; N Muszbek; E Richardet; A Lingua; C Charbonneau; E Remák

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness evaluation of sunitin

✍ Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Mar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 451 KB

Economic evaluation of sunitinib malate

✍ Timo Purmonen; Janne A. Martikainen; Erkki J.O. Soini; Vesa Kataja; Riikka-Liisa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 839 KB

PCN46 PHARMACOECONOMIC EVALUATION OF SUN

✍ C Tenorio; J Vargas; P Rizo-Rios; O Flores-Gil; J Martínez-Fonseca; J Mould-Quev 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

PCN77 COST-EFFECTIVENESS ANALYSIS OF TEM

✍ NM Silverio; S Yang; E Alemao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

PCN70 COST EFFECTIVENESS ANALYSIS OF SUN

✍ E Remák; H Vioix; R Sandin; U Harmenberg; A Ullén; P Sandström 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN101 Cost Effectiveness of Everolimus

✍ J. Mihajlović; P. Pechlivanoglou; A. Sabo; Z. Tomić; M.J. Postma 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB